Table of Contents
This report, Next Generation Sequencing in Latin America, is a look at the use of DNA sequencing systems in the region, based on Survey conducted by VA Consultadoros in Fall 2013. The survey focused on instrumentation, with a goal of providing a complete count of NGS systems sold to customers in key Latin American Countries.
Latin America is a focus for healthcare markets. During 2000-2010 the region went through its highest economic growth period in the last four decades. Economics brought almost a third of the total population in the region into the
middle class status—with around 70 percent of them living in Brazil, Mexico and Argentina. The economic development has translated into investment in these nation's healthcare systems, which in terms has increased the focus on high-end biotechnology instrument spending for clinical research and diagnostics.
Genomics studies product cycle with Next Generation Sequencing (NGS) technology in Latin America (LatAm) is in its exponential phase and market growth is larger than the regional investment in Science and Technology (S&T) compared against the expenditure in S&T as a percentage of GDP. Because of that is necessary to know more details about the market dynamics, products/applications segmentation and main purchase drivers.
As part of its coverage, this report contains the following data:
Number of Next Generation Sequencing Systems Installed by Country
Brands of Next Generation Sequencing Systems Installed In Latin America, Cross-Referenced By Country
Next Generation Sequencing Systems by Throughput Category
The survey was performed interviewing Distributors with local or regional presence, opinion leaders, manufacturers of systems and reagents for the Life Sciences market segment, research institutes and tender’s calls. Twenty two interviews were performed that let gather information about eight countries (Argentina, Brazil, Chile, Colombia, Mexico, Panama, Peru and Uruguay) along the period June/September 2013.
This market survey and analysis shows information about geographical distribution, lab category distribution, manufacturer’s analysis, instruments distribution by throughput category and market trends for the coming years. As part of its coverage, applications were not in the scope of this report.
The report is collaboration between Kalorama Information and VA Consultora y Asociados. VA Consultora y Asociados is a consultant company founded and directed by Dr. María Victoria Allais, with more than 20 years in the IVD market and its different segments. Internal knowledge and expertise lead to real time intelligence on the diagnostic market including new technologies and forecasting. In-depth qualitative and quantitative research focused on LATAM region and country specific trends. More information is available at: www.vaconsultora.com.ar
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The global non-invasive prenatal testing (NIPT) market is projected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the ...
The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, ...
The global high throughput process development market is expected to reach USD 19.78 billion in 2021 from USD 9.91 billion in 2016, at a CAGR of 14.8% from 2016 to 2021. Growth in the high throughput process ...